Atea Pharmaceuticals, Inc. (AVIR) Revenue 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$351.4MFY2022 · since FY2021: $48.6M → $351.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $351.4M | +622.5% |
| FY2021 | $48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice